Profits before people?: ethical standards and the marketing of prescription drugs
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Bloomington
Indiana University Press
©2006
|
| Schriftenreihe: | Bioethics and the humanities
|
| Schlagworte: | |
| Online-Zugang: | FAW01 FAW02 Volltext |
| Beschreibung: | Includes bibliographical references (pages 185-197) and index Ethics and for-profit business -- The pharmaceutical industry and its stakeholders -- Drug companies and healthcare professionals : the ethics agenda -- Medical professionalism and scientific integrity -- The industry's code : not good enough -- Drug samples : the most important gifts -- Marketing is not objective education -- Medical education : industry at arm's length -- Clinical research and the limits of commercial interests -- Citizens and consumers -- Direct-to-consumer advertising : conflicting interests -- Direct-to-consumer advertising : better is better Includes information on advertising, conflicts of interest, cost of pharmaceuticals, direct to consumer advertising, advertising to patients, Pfizer, pricing of pharmaceuticals, profit motive, samples of pharmaceuticals, etc |
| Beschreibung: | 1 Online-Ressource (206 pages) |
| ISBN: | 0253112109 9780253112101 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043087691 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s2006 |||| o||u| ||||||eng d | ||
| 020 | |a 0253112109 |c electronic bk. |9 0-253-11210-9 | ||
| 020 | |a 9780253112101 |c electronic bk. |9 978-0-253-11210-1 | ||
| 035 | |a (OCoLC)122253282 | ||
| 035 | |a (DE-599)BVBBV043087691 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 174/.96151 |2 22 | |
| 100 | 1 | |a Weber, Leonard J. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Profits before people? |b ethical standards and the marketing of prescription drugs |c Leonard J. Weber |
| 264 | 1 | |a Bloomington |b Indiana University Press |c ©2006 | |
| 300 | |a 1 Online-Ressource (206 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Bioethics and the humanities | |
| 500 | |a Includes bibliographical references (pages 185-197) and index | ||
| 500 | |a Ethics and for-profit business -- The pharmaceutical industry and its stakeholders -- Drug companies and healthcare professionals : the ethics agenda -- Medical professionalism and scientific integrity -- The industry's code : not good enough -- Drug samples : the most important gifts -- Marketing is not objective education -- Medical education : industry at arm's length -- Clinical research and the limits of commercial interests -- Citizens and consumers -- Direct-to-consumer advertising : conflicting interests -- Direct-to-consumer advertising : better is better | ||
| 500 | |a Includes information on advertising, conflicts of interest, cost of pharmaceuticals, direct to consumer advertising, advertising to patients, Pfizer, pricing of pharmaceuticals, profit motive, samples of pharmaceuticals, etc | ||
| 650 | 7 | |a BUSINESS & ECONOMICS / Business Ethics |2 bisacsh | |
| 650 | 7 | |a Marketing / Moral and ethical aspects |2 fast | |
| 650 | 7 | |a Pharmaceutical industry / Moral and ethical aspects |2 fast | |
| 650 | 4 | |a Drug Industry / ethics / United States | |
| 650 | 4 | |a Drug Industry / economics / United States | |
| 650 | 4 | |a Marketing / ethics / United States | |
| 650 | 4 | |a Pharmaceutical Preparations / United States | |
| 650 | 4 | |a Ethik | |
| 650 | 4 | |a Wirtschaft | |
| 650 | 4 | |a Pharmaceutical industry |x Moral and ethical aspects |z United States | |
| 650 | 4 | |a Marketing |x Moral and ethical aspects |z United States | |
| 650 | 0 | 7 | |a Unternehmensethik |0 (DE-588)4202404-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Ethik |0 (DE-588)4015602-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Wirtschaftsethik |0 (DE-588)4066439-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelmarkt |0 (DE-588)4003131-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Vermarktung |0 (DE-588)4121857-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelsicherheit |0 (DE-588)4143182-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd |9 rswk-swf |
| 651 | 4 | |a USA | |
| 651 | 7 | |a USA |0 (DE-588)4078704-7 |2 gnd |9 rswk-swf | |
| 689 | 0 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 0 | 1 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 0 | 2 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 0 | 3 | |a Vermarktung |0 (DE-588)4121857-7 |D s |
| 689 | 0 | 4 | |a Ethik |0 (DE-588)4015602-3 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 689 | 1 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 1 | 1 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 1 | 2 | |a Arzneimittelsicherheit |0 (DE-588)4143182-0 |D s |
| 689 | 1 | 3 | |a Unternehmensethik |0 (DE-588)4202404-3 |D s |
| 689 | 1 | |8 2\p |5 DE-604 | |
| 689 | 2 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 2 | 1 | |a Arzneimittelmarkt |0 (DE-588)4003131-7 |D s |
| 689 | 2 | 2 | |a Wirtschaftsethik |0 (DE-588)4066439-9 |D s |
| 689 | 2 | |8 3\p |5 DE-604 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 0-253-34748-3 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 978-0-253-34748-0 |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=187153 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028511883 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 3\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=187153 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=187153 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175485648764928 |
|---|---|
| any_adam_object | |
| author | Weber, Leonard J. |
| author_facet | Weber, Leonard J. |
| author_role | aut |
| author_sort | Weber, Leonard J. |
| author_variant | l j w lj ljw |
| building | Verbundindex |
| bvnumber | BV043087691 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)122253282 (DE-599)BVBBV043087691 |
| dewey-full | 174/.96151 |
| dewey-hundreds | 100 - Philosophy & psychology |
| dewey-ones | 174 - Occupational ethics |
| dewey-raw | 174/.96151 |
| dewey-search | 174/.96151 |
| dewey-sort | 3174 596151 |
| dewey-tens | 170 - Ethics (Moral philosophy) |
| discipline | Philosophie |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04686nmm a2200865zc 4500</leader><controlfield tag="001">BV043087691</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2006 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0253112109</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-253-11210-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780253112101</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-253-11210-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)122253282</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043087691</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">174/.96151</subfield><subfield code="2">22</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Weber, Leonard J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Profits before people?</subfield><subfield code="b">ethical standards and the marketing of prescription drugs</subfield><subfield code="c">Leonard J. Weber</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Bloomington</subfield><subfield code="b">Indiana University Press</subfield><subfield code="c">©2006</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (206 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Bioethics and the humanities</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (pages 185-197) and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Ethics and for-profit business -- The pharmaceutical industry and its stakeholders -- Drug companies and healthcare professionals : the ethics agenda -- Medical professionalism and scientific integrity -- The industry's code : not good enough -- Drug samples : the most important gifts -- Marketing is not objective education -- Medical education : industry at arm's length -- Clinical research and the limits of commercial interests -- Citizens and consumers -- Direct-to-consumer advertising : conflicting interests -- Direct-to-consumer advertising : better is better</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes information on advertising, conflicts of interest, cost of pharmaceuticals, direct to consumer advertising, advertising to patients, Pfizer, pricing of pharmaceuticals, profit motive, samples of pharmaceuticals, etc</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">BUSINESS & ECONOMICS / Business Ethics</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Marketing / Moral and ethical aspects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmaceutical industry / Moral and ethical aspects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry / ethics / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry / economics / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Marketing / ethics / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical Preparations / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ethik</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Wirtschaft</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Moral and ethical aspects</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Marketing</subfield><subfield code="x">Moral and ethical aspects</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Unternehmensethik</subfield><subfield code="0">(DE-588)4202404-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Ethik</subfield><subfield code="0">(DE-588)4015602-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wirtschaftsethik</subfield><subfield code="0">(DE-588)4066439-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelmarkt</subfield><subfield code="0">(DE-588)4003131-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Vermarktung</subfield><subfield code="0">(DE-588)4121857-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelsicherheit</subfield><subfield code="0">(DE-588)4143182-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Vermarktung</subfield><subfield code="0">(DE-588)4121857-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="4"><subfield code="a">Ethik</subfield><subfield code="0">(DE-588)4015602-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Arzneimittelsicherheit</subfield><subfield code="0">(DE-588)4143182-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="3"><subfield code="a">Unternehmensethik</subfield><subfield code="0">(DE-588)4202404-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Arzneimittelmarkt</subfield><subfield code="0">(DE-588)4003131-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Wirtschaftsethik</subfield><subfield code="0">(DE-588)4066439-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">0-253-34748-3</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">978-0-253-34748-0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=187153</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028511883</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=187153</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=187153</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| geographic | USA USA (DE-588)4078704-7 gnd |
| geographic_facet | USA |
| id | DE-604.BV043087691 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:17:02Z |
| institution | BVB |
| isbn | 0253112109 9780253112101 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028511883 |
| oclc_num | 122253282 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (206 pages) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2006 |
| publishDateSearch | 2006 |
| publishDateSort | 2006 |
| publisher | Indiana University Press |
| record_format | marc |
| series2 | Bioethics and the humanities |
| spelling | Weber, Leonard J. Verfasser aut Profits before people? ethical standards and the marketing of prescription drugs Leonard J. Weber Bloomington Indiana University Press ©2006 1 Online-Ressource (206 pages) txt rdacontent c rdamedia cr rdacarrier Bioethics and the humanities Includes bibliographical references (pages 185-197) and index Ethics and for-profit business -- The pharmaceutical industry and its stakeholders -- Drug companies and healthcare professionals : the ethics agenda -- Medical professionalism and scientific integrity -- The industry's code : not good enough -- Drug samples : the most important gifts -- Marketing is not objective education -- Medical education : industry at arm's length -- Clinical research and the limits of commercial interests -- Citizens and consumers -- Direct-to-consumer advertising : conflicting interests -- Direct-to-consumer advertising : better is better Includes information on advertising, conflicts of interest, cost of pharmaceuticals, direct to consumer advertising, advertising to patients, Pfizer, pricing of pharmaceuticals, profit motive, samples of pharmaceuticals, etc BUSINESS & ECONOMICS / Business Ethics bisacsh Marketing / Moral and ethical aspects fast Pharmaceutical industry / Moral and ethical aspects fast Drug Industry / ethics / United States Drug Industry / economics / United States Marketing / ethics / United States Pharmaceutical Preparations / United States Ethik Wirtschaft Pharmaceutical industry Moral and ethical aspects United States Marketing Moral and ethical aspects United States Unternehmensethik (DE-588)4202404-3 gnd rswk-swf Ethik (DE-588)4015602-3 gnd rswk-swf Wirtschaftsethik (DE-588)4066439-9 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Arzneimittelmarkt (DE-588)4003131-7 gnd rswk-swf Vermarktung (DE-588)4121857-7 gnd rswk-swf Arzneimittelsicherheit (DE-588)4143182-0 gnd rswk-swf Pharmazeutische Industrie (DE-588)4045696-1 gnd rswk-swf USA USA (DE-588)4078704-7 gnd rswk-swf USA (DE-588)4078704-7 g Pharmazeutische Industrie (DE-588)4045696-1 s Arzneimittel (DE-588)4003115-9 s Vermarktung (DE-588)4121857-7 s Ethik (DE-588)4015602-3 s 1\p DE-604 Arzneimittelsicherheit (DE-588)4143182-0 s Unternehmensethik (DE-588)4202404-3 s 2\p DE-604 Arzneimittelmarkt (DE-588)4003131-7 s Wirtschaftsethik (DE-588)4066439-9 s 3\p DE-604 Erscheint auch als Druck-Ausgabe, Hardcover 0-253-34748-3 Erscheint auch als Druck-Ausgabe, Hardcover 978-0-253-34748-0 http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=187153 Aggregator Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 3\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Weber, Leonard J. Profits before people? ethical standards and the marketing of prescription drugs BUSINESS & ECONOMICS / Business Ethics bisacsh Marketing / Moral and ethical aspects fast Pharmaceutical industry / Moral and ethical aspects fast Drug Industry / ethics / United States Drug Industry / economics / United States Marketing / ethics / United States Pharmaceutical Preparations / United States Ethik Wirtschaft Pharmaceutical industry Moral and ethical aspects United States Marketing Moral and ethical aspects United States Unternehmensethik (DE-588)4202404-3 gnd Ethik (DE-588)4015602-3 gnd Wirtschaftsethik (DE-588)4066439-9 gnd Arzneimittel (DE-588)4003115-9 gnd Arzneimittelmarkt (DE-588)4003131-7 gnd Vermarktung (DE-588)4121857-7 gnd Arzneimittelsicherheit (DE-588)4143182-0 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd |
| subject_GND | (DE-588)4202404-3 (DE-588)4015602-3 (DE-588)4066439-9 (DE-588)4003115-9 (DE-588)4003131-7 (DE-588)4121857-7 (DE-588)4143182-0 (DE-588)4045696-1 (DE-588)4078704-7 |
| title | Profits before people? ethical standards and the marketing of prescription drugs |
| title_auth | Profits before people? ethical standards and the marketing of prescription drugs |
| title_exact_search | Profits before people? ethical standards and the marketing of prescription drugs |
| title_full | Profits before people? ethical standards and the marketing of prescription drugs Leonard J. Weber |
| title_fullStr | Profits before people? ethical standards and the marketing of prescription drugs Leonard J. Weber |
| title_full_unstemmed | Profits before people? ethical standards and the marketing of prescription drugs Leonard J. Weber |
| title_short | Profits before people? |
| title_sort | profits before people ethical standards and the marketing of prescription drugs |
| title_sub | ethical standards and the marketing of prescription drugs |
| topic | BUSINESS & ECONOMICS / Business Ethics bisacsh Marketing / Moral and ethical aspects fast Pharmaceutical industry / Moral and ethical aspects fast Drug Industry / ethics / United States Drug Industry / economics / United States Marketing / ethics / United States Pharmaceutical Preparations / United States Ethik Wirtschaft Pharmaceutical industry Moral and ethical aspects United States Marketing Moral and ethical aspects United States Unternehmensethik (DE-588)4202404-3 gnd Ethik (DE-588)4015602-3 gnd Wirtschaftsethik (DE-588)4066439-9 gnd Arzneimittel (DE-588)4003115-9 gnd Arzneimittelmarkt (DE-588)4003131-7 gnd Vermarktung (DE-588)4121857-7 gnd Arzneimittelsicherheit (DE-588)4143182-0 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd |
| topic_facet | BUSINESS & ECONOMICS / Business Ethics Marketing / Moral and ethical aspects Pharmaceutical industry / Moral and ethical aspects Drug Industry / ethics / United States Drug Industry / economics / United States Marketing / ethics / United States Pharmaceutical Preparations / United States Ethik Wirtschaft Pharmaceutical industry Moral and ethical aspects United States Marketing Moral and ethical aspects United States Unternehmensethik Wirtschaftsethik Arzneimittel Arzneimittelmarkt Vermarktung Arzneimittelsicherheit Pharmazeutische Industrie USA |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=187153 |
| work_keys_str_mv | AT weberleonardj profitsbeforepeopleethicalstandardsandthemarketingofprescriptiondrugs |